Comparison of Clinical Profiles, Demographics, and Surgical Outcomes of 25-Gauge Vitrectomy for Proliferative Diabetic Retinopathy in Young Adults with Type 1 or Type 2 Diabetes

References

• Patricia B, Andrew JB, David OH, Brian GM. Ocular sequelae in a population-based cohort of youth diagnosed with diabetes during a 50-year period. JAMA Ophthalmol. 2022;140(1):51–57. doi:10.1001/jamaophthalmol.2021.5052
   PubMed Web of Science ®Google Scholar
• Xuexin Y, Fan X, Wei Z. Trends and geographic variations in self-reported diabetes incidence: a prospective open cohort study of Chinese men and women, 1997–2015. Diabet Med. 2021;38(7):e14447. doi:10.1111/dme.14447
   PubMed Web of Science ®Google Scholar
• Joanna YLT, Elaine YWK, Betty WMB, et al. Incidence and clinical characteristics of pediatric-onset type 2 diabetes in Hong Kong: the Hong Kong childhood diabetes registry 2008 to 2017. Pediatr Diabetes. 2022;23(5):556–561. doi:10.1111/pedi.13231
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S002
   PubMed Web of Science ®Google Scholar
• Fu J, Prasad HC. Changing epidemiology of metabolic syndrome and type 2 diabetes in Chinese youth. Curr Diab Rep. 2014;14(1):447. doi:10.1007/s11892-013-0447-z
   PubMed Web of Science ®Google Scholar
• Wei JN, Sung FC, Lin CC, Lin RS, Chiang CC, Chuang LM. National surveillance for type 2 diabetes mellitus in Taiwanese children. JAMA. 2003;290(10):1345–1350. doi:10.1001/jama.290.10.1345
   PubMed Web of Science ®Google Scholar
• Urakami T, Suzuki J, Mugishima H, et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatric Endocrinol Rev. 2012;10(Suppl 1):51–61.
   PubMedGoogle Scholar
• Hui JC, Chang GW, Hong LD, Xue FF, Yi MX, Zhi ZM. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young adults with proliferative diabetic retinopathy. Ann Palliat Med. 2020;9(1):82–89. doi:10.21037/apm.2020.01.10
   PubMed Web of Science ®Google Scholar
• Simunovic MP, Maberley DA. Anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy: a systematic review and meta-analysis. Retina. 2015;35(10):1931–1942. doi:10.1097/IAE.0000000000000723
   PubMed Web of Science ®Google Scholar
• Liao M, Wang X, Yu J, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmol. 2020;20(1):416. doi:10.1186/s12886-020-01688-3
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311:1778–1786. doi:10.1001/jama.2014.3201
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Khurana RN, Nguyen QD, et al. Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy. Diabetes Care. 2021;44(3):748–756. doi:10.2337/dc20-0413
   PubMed Web of Science ®Google Scholar
• Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–970. doi:10.2337/dc17-1962
   PubMed Web of Science ®Google Scholar
• Lueder GT, Silverstein J. American Academy of Pediatrics section on ophthalmology and section on endocrinology. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116(1):270–273. doi:10.1542/peds.2005-0875
   PubMedGoogle Scholar
• Zhang M, Gezhi X, Ruan L, Huang X, Zhang T. Clinical characteristics and surgical outcomes of complications of proliferative diabetic retinopathy in young versus older patients with type 2 diabetes. Diabetes Metab Syndr Obes. 2023;11(16):37–45. doi:10.2147/DMSO.S382603
   Google Scholar
• Porter M, Channa R, Wagner J, Prichett L, Liu TYA, Wolf RM. Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center. Pediatr Diabetes. 2020;21(5):856–862. doi:10.1111/pedi.13037
   PubMed Web of Science ®Google Scholar
• Tapley JL, G M Jr, Ashraf AP, et al. Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study. Diabetol Metab Syndr. 2015;24(7):56. doi:10.1186/s13098-015-0054-z
   Google Scholar
• Anna EE, Ulf S, Annika J, Annelie C, Amira E, Claude M. Microalbuminuria and retinopathy in adolescents and young adults with type 1 and type 2 diabetes. Pediatr Diabetes. 2020;21(7):1310–1321. doi:10.1111/pedi.13074
   PubMed Web of Science ®Google Scholar
• Wang TL, Xia G, Wei W, et al. Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes. BMJ Open. 2022;12(5):e056332. doi:10.1136/bmjopen-2021-056332
   PubMed Web of Science ®Google Scholar
• Renu AK. Retinopathy in a diet-induced type 2 diabetic rat model and role of epigenetic modifications. Diabetes. 2020;69(4):689–698. doi:10.2337/db19-1009
   PubMed Web of Science ®Google Scholar
• Anastasios S, Vasileios G, Eleni PK, Assimina GT, Ekaterini S. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021;12(4):344–365. doi:10.4239/wjd.v12.i4.344
   PubMed Web of Science ®Google Scholar
• Li S, Tang J, Han X, et al. Prospective comparison of surgery outcome between preoperative and intraoperative intravitreal injection of ranibizumab for vitrectomy in proliferative diabetic retinopathy patients. Ophthalmol Ther. 2022;11(5):1833–1845. doi:10.1007/s40123-022-00550-7
   PubMed Web of Science ®Google Scholar
• Yun DS, Chung MY. Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: a long-term follow-up study. Eur J Ophthalmol. 2007;17(6):954–960. doi:10.1177/112067210701700614
   PubMed Web of Science ®Google Scholar
• Brourman ND, Blumenkranz MS, Cox MS, Trese MT. Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology. 1989;96(6):759–764. doi:10.1016/S0161-6420(89)32828-4
   PubMed Web of Science ®Google Scholar
• Huang CH, Hsieh YT, Yang CM. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255(5):863‑871. doi:10.1007/s00417-016-3579-4
   Web of Science ®Google Scholar
• Sun D, Lin Y, Zeng R, Yang Z, Deng X, Lan Y. The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy. Eur J Ophthalmol. 2021;31(6):3057–3067. doi:10.1177/1120672120980686
   PubMed Web of Science ®Google Scholar
• Katsuhiro N, Koichi N, Teiko Y, Hidetoshi Y. Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy. PLoS One. 2021;16(1):e0244281. doi:10.1371/journal.pone.0244281
   PubMed Web of Science ®Google Scholar
• Karthik K, Girish B, Naresh B, et al. Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study. Indian J Ophthalmol. 2021;69(11):3289–3295. doi:10.4103/ijo.IJO_1293_21
   PubMed Web of Science ®Google Scholar
• Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(3):365–368. doi:10.1136/bjo.2007.124495
   PubMed Web of Science ®Google Scholar
• Lin T, Gubitosi KRA, Channa R, Wolf RM. Pediatric diabetic retinopathy: updates in prevalence, risk factors, screening, and management. Curr Diab Rep. 2021;21(12):56. doi:10.1007/s11892-021-01436-x
   PubMed Web of Science ®Google Scholar